Literature DB >> 20004006

Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.

M Anna Kowalska1, Lubica Rauova, Mortimer Poncz.   

Abstract

Chemokines are a family of small proteins that have significant roles in inflammation, angiogenesis and cellular homing. Since inflammation and hemostasis/thrombosis have multiple overlapping roles and pathways, one could expect that some chemokines would also have biologically significant roles in hemostasis/thrombosis as well. This would especially be true for chemokines that are localized solely or predominantly within platelets and released in large amounts at sites of platelet activation such as platelet factor 4 (PF4, CXCL4) and its closely related chemokine, platelet basic protein (PBP, CXCL7). Our group and others have clearly demonstrated an in vivo role for PF4 in hemostasis/thrombosis, but not for PBP, which in contrast has clear proinflammatory properties. This review will focus on PF4 and its potential roles in hemostasis/thrombosis and the underlying pathways by which PF4 may be especially important in such pathologic thrombotic states as heparin-induced thrombocytopenia (HIT) and septic shock. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004006     DOI: 10.1016/j.thromres.2009.11.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  61 in total

1.  Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.

Authors:  Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  Am J Respir Crit Care Med       Date:  2012-01-06       Impact factor: 21.405

2.  Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.

Authors:  Katherine E Poruk; Matthew A Firpo; Luke M Huerter; Courtney L Scaife; Lyska L Emerson; Kenneth M Boucher; Kimberly A Jones; Sean J Mulvihill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-20       Impact factor: 4.254

3.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

4.  Chebulagic acid inhibits the LPS-induced expression of TNF-α and IL-1β in endothelial cells by suppressing MAPK activation.

Authors:  Yueying Liu; Luer Bao; Liying Xuan; Baohua Song; Lin Lin; Hao Han
Journal:  Exp Ther Med       Date:  2015-04-23       Impact factor: 2.447

5.  Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability.

Authors:  Hidemi Hattori; Masayuki Ishihara
Journal:  Exp Ther Med       Date:  2017-01-13       Impact factor: 2.447

6.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

7.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

Review 8.  The role of platelets in tumour growth.

Authors:  K Pilatova; L Zdrazilova-Dubska; G L Klement
Journal:  Klin Onkol       Date:  2012

Review 9.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

10.  Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.

Authors:  Melissa S Love; Melanie G Millholland; Satish Mishra; Swapnil Kulkarni; Katie B Freeman; Wenxi Pan; Robert W Kavash; Michael J Costanzo; Hyunil Jo; Thomas M Daly; Dewight R Williams; M Anna Kowalska; Lawrence W Bergman; Mortimer Poncz; William F DeGrado; Photini Sinnis; Richard W Scott; Doron C Greenbaum
Journal:  Cell Host Microbe       Date:  2012-12-13       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.